IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Teva Pharmaceuticals Inc. opposition analysis
COMPANY ANALYSIS
Latest oppositions filed by Teva Pharmaceuticals Inc.
Patent Number:
EP2269603
Title:
Treatment Of Solid Tumours With Rapamycin Derivatives
Applicant:
NOVARTIS AG
Opposition Date:
Feb 18, 2016
Latest oppositions filed by Teva Pharmaceuticals Inc.
Patent Number
Title
Applicant
Opposition Date
EP2269603
Treatment Of Solid Tumours With Rapamycin Derivatives
NOVARTIS AG
Feb 18, 2016
Competitors of Teva Pharmaceuticals Inc.
NOVARTIS AG
NOVARTIS PHARMA GMBH
Want to track Teva Pharmaceuticals Inc.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch